Pharmerica Publications
2007

To jump to a specific SUGDIS publication, click on the title:

Current Literature and Information for Pharmacists (CLIPS)
New Drug FAX Sheet
Pharmacy Precis
Index 4th Quarter

Current Literature and Information for Pharmacists (CLIPs):
2007, Vol 11

Issue 
Number		 Date Title
62
 Dec 31 CAM Education For Health Care Professionals
61
 Dec 24 Community Pharmacy Immunizations and Collaborative Practice
60
 Dec 10 Managing Asymptomatic Bacteriuria
59
 Dec 3 Guidelines for the Prevention of Infective Endocarditis
58
 Nov 26 Identifying and Treating Pediatric Obesity
57
 Nov 19 Reassessment of Rosiglitazone Adverse Event Data
56
 Nov 19 Forteo vs. Fosamax for Glucocorticoid-Induced Osteoporosis
55
 Nov 5 Assessment of Oral Diabetes Agents
54
 Oct 29 Glucosamine and Chondroitin for Knee and Hip Osteoarthritis
53
 Oct 22 Risks and Benefits of COX-2 Inhibitors and NSAIDs
52
 Oct 15 Cardiovascular Health and Alcohol Consumption
51
 Oct 11 Assessing Pioglitazone for Cardiovascular Events
50
 Oct 11 Long-Term Rosiglitazone Use & Cardiovascular Events
49
 Oct 2 Pharmacotherapy Options for Smoking Cessation
48
 Oct 1 Assessment of Antimicrobial Dosing in Obese Adult Patients
47
 Sep 24 Identification and Management of Carpal Tunnel Syndrome
46
 Sep 17 Diabetes Update
45
 Sep 3 Stress Ulcer Prophylaxis in General Medicine Patients
44
 Aug 27 Blood Glucose Control in ICU Patients
43
 Aug 20 Understanding Abnormal Coagulation Tests
42
 Aug 6 Recombinant Activated Human Factor VII: Off-Label Use
41
 Jul 30 Hypertension Therapy and Ischemic Heart Disease
40
 Jul 27 Managing Acute Ischemic Stroke in Adult Patients
39
 Jul 23 Treating Psychotic Disorders with Second-Generation Antipsychotics
38
 Jul 16 Complications of Type 2 Diabetes in Adolescents
37
 Jul 11 Update to Tolvaptan in Heart Failure
36
 Jul 5 Rosiglitazone Adverse Event Update: RECORD Study
35
 Jul 5 Rosiglitazone Cardiovascular Adverse Events: The Beginning
34
 Jul 2 Standards of Medical Care in Diabetes
33
 Jun 25 Type 2 Diabetes in Children
32
 Jun 22 USP Chapter <797> Update
31
 Jun 18 Reduction of Trans Fatty Acids in the American Diet
30
 Jun 15 Daily Aspirin Dose for Cardiovascular Disease Prophylaxis
29
 Jun 11 Community-Acquired Pneumonia Update
28
 Jun 4 Modification of Diet in Renal Disease Equation and Pharmacy
27
 May 29 Management of Menopause
26
 May 22 Tolvaptan in Patients with Heart Failure
25
 May 21 Colorectal Cancer Prevention: NSAIDS/Cox-2 Inhibitors
24
 May 14 Nonsteroidal Antiinflammatory Drug Use Update
23
 Apr 30 Recommendations for the Use of Quadrivalent Human Papillomavirus Vaccine
22
 Apr 23 In-Store Clinics
21
 Apr 19 Consensus Statement: Botulinum Neurotoxin to Treat Spasticity
20
 Apr 17 Xigris® in Children with Severe Sepsis
19
 Apr 16 Human Papillomavirus (HPV) Prevalence in the USA
18
 Apr 13 Exenatide/TZD Combination for Type 2 Diabetes
17
 Apr 2 Infectious Endocarditis: Pros and Cons of Prophylaxis
16
 Mar 26 The Past and Future of Fibrate Therapy
15
 Mar 19 Safety Considerations in Attention Deficit Hyperactivity Disorder Treatment
14
 Mar 5 Nutritional Intervention for Diabetes (Part 2of 2)
13
 Mar 5 Osteoporosis: Improving Patient Compliance
12
 Feb 28 Nutritional Intervention for Diabetes (Part 1 of 2)
11
 Feb 28 Consultant Pharmacist and Nursing Home Physician Relationships
10
 Feb 26 COX-2 Inhibitors and Cardiovascular Disease
9
 Feb 19 Treating Acute Ischemic Stroke
8
 Feb 5 Serotonin Syndrome Risk with Linezolid and SSRIs
7
 Jan 30 Treatment Guidelines: Surgical Antibiotic Prophylaxis
6
 Jan 29 Meta-Analysis of Folic Acid and Cardiovascular Disease
5
 Jan 26 Nutrition and Physical Activity During and After Cancer Treatment
4
 Jan 22 Clostridium Difficile: Resisting Resistance
3
 Jan 15 Assessment of Propoxyphene Use
2
 Jan 8 Restless Leg Syndrome
1
 Jan 2 Practical Suggestions for Treating Epilepsy

Return to Top

New Drug FAX Sheet:
2007, Vol 11

Issue 
Number		 Date
Title
53
 Dec 26 Fentanyl Patch Safety Update
52
 Dec 21 Serious Skin Reactions with Carbamazepine
51
 Dec 21 Doripenem (Doribax® Ortho-McNeil Janssen)
50
 Dec 20 Zoledronic Acid (Reclast®, Novartis)
49
 Dec 17 New Drug Approvals
48
 Dec 11 PPIs Do Not Increase Cardiac Event Risk
47
 Dec 5 New Safety Data for Desmopressin (DDVAP)
46
 Nov 21 New Safety Data with Chantix®
45
 Nov 15 Ongoing Safety Review of Cefepime (Maxipime)
44
 Nov 15 Myocardial Infarction Box Warning Added to Rosiglitazone
43
 Nov 12 New Drug Approvals
42
 Oct 26 Increased Risk of Death Associated with Aprotinin Use
41
 Oct 19 Pfizer Discontinues Exubera (Insulin Human [rDNA Origin] Inhalation Powder Manufacturing
40
 Oct 10 Pancreatitis Associated with Exenatide (Byetta) Use
39
 Oct 8 New Drug Approvals
38
 Oct 2 Possible Association of Atrial Fibrillation with Bisphosphonates
37
 Sep 11 Fatal Ceftriaxone Interactions with Calcium-Containing Products
36
 Sep 10 New Drug Approvals
35
 Aug 17 Genetic Enzyme Variations and Warfarin Therapy
34
 Aug 16 FDA Recommendations for OTC Cough and Cold Medication Usage in Children
33
 Aug 15 FDA Requires Boxed Warning for all Thiazolidinedione-Containing Products
32
 Aug 13 New Drug Approvals
31
 Aug 1 Avandia® Remains on the Market
30
 Jul 27 Restricted® Zelnorm Use Allowed
29
 Jul 26 Seroquel® XR
28
 Jul 20 Byetta® and Symlin® Comparison
27
 Jul 18 Transdermal Exelon®
26
 Jul 9 New Drug Approvals
25
 Jul 6 Updated Package Labeling for Rocephin
24
 Jul 6 Revised Package Labeling for Xolair
23
 Jul 2 Fatal Reaction Associated with Inhaled Colistimethate Solution
22
 Jun 18 Illness Due to Propofol (Diprivan®) Administration
21
 May 23 Additional Information Regarding Avandia and Cardiovascular Risks
20
 May 22 New Cardiovascular Warnings for Avandia (Rosiglitazone)
19
 May 7 New Drug Approvals
18
 Apr 9 New Drug Approvals
17
 Apr 3 Dopamine Agonists Conversion Schedule
16
 Mar 30 Zelnorm (Tegaserod) Removed from Market
15
 Mar 30 Pergolide Removed from Market
14
 Mar 30 Lisdexamfetamine Dimesylate (Vyvanse®, Shire)
13
 Mar 19

New Considerations for Administration of Linezolid (Zyvox) for Catheter-Related Bloodstream Infections
12
 Mar 12 New Drug Formulations
11
 Mar 9 Pioglitazone-Containing Products Associated with Fractures in Females
10
 Feb 22 Patient Medication Guides Required for all ADHD Medications
9
 Feb 22 Anaphylaxis Associated with Omalizumab (Xolair®) Therapy
8
 Feb 21 Rosiglitazone-Associated Fractures in Females Prompts Further Analyses
7
 Feb 19 New Safety Concerns for Erythropoiesis-Stimulating agents (ESA)
6
 Feb 13 Labeling Revisions for Telithromycin (Ketek® )
5
 Feb 12 New Drug Approvals
4
 Feb 2 Intravitreal Ranibizumab Therapy Associated with Stroke
3
 Feb 2 Warning for Aranesp® Use in Selected Anemia Types
2
 Feb 1 Paliperidone-ER (Invega®, Janssen)
1
 Jan 31 Sitagliptin (Januvia®, Merck)
Return to Top
 
 

Pharmacy Precis:
2007, Vol 24

Issue
Number		 Date Title
3
 Oct 07 Advisory Committee on Immunization Practices (ACIP) Recommendations for the
Prevention and Control of Influenza
2
 Aug 07 SUGDIS 2006 Quality Assurance Survey Results
1
Jan 07 New Molecular Entities of 2006
Return to Top

Back to DIC Services